HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urokinase-type plasminogen activator in ascites obtained from the patient with mammary cancer.

Abstract
Plasminogen activator (ascites PA) was purified from the ascites of the patient with breast cancer using lysine-Sepharose, salting out, DEAE Sephadex A-50 and anti-urokinase (UK) Sepharose chromatography. The ascites PA was adsorbed on anti-UK Sepharose and its activity was neutralized by anti-UK IgG fraction. The molecular weights of the ascites PA proteins were 70,000, 32,000 and 25,000 daltons. The ascites PA activated plasminogen and showed amidolytic activity for S-2444. Zymograms of ascites PA showed that 70,000 and 32,000 daltons proteins had a PA activity. The ascites PA thus contained two types of PAs, one was similar to LMW-UK and the other was an UK type tissue PA.
AuthorsS Hayashi, K Yamada
JournalThrombosis research (Thromb Res) Vol. 38 Issue 5 Pg. 459-67 (Jun 01 1985) ISSN: 0049-3848 [Print] United States
PMID4040279 (Publication Type: Journal Article)
Chemical References
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator
Topics
  • Ascites (enzymology)
  • Breast Neoplasms (enzymology)
  • Female
  • Humans
  • Immunochemistry
  • Middle Aged
  • Molecular Weight
  • Plasminogen Activators (isolation & purification)
  • Urokinase-Type Plasminogen Activator (immunology, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: